2-Pentylcyclohex-2-en-1-one
Common Name: |
2-Pentylcyclohex-2-en-1-one |
IUPAC Name: |
2-pentylcyclohex-2-en-1-one |
Molecular Formula: |
C9H16O4 |
SMILES: |
CCCCCC1=CCCCC1=O |
Inchi: |
1S/C11H18O/c1-2-3-4-7-10-8-5-6-9-11(10)12/h8H,2-7,9H2,1H3 |
Inchi Key: |
UDFUFXGJDJZSJD-UHFFFAOYSA-N |
Cas No: |
25435-63-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
188.22 |
Mass (g/mol) |
166.136 |
Molar Refractivity |
47.95 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
7 |
Rings |
1 |
TPSA |
52.60 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
257.00 to 258.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.014 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.78 |
LogP |
3.246 |
iLOGP |
2.28 |
XLOGP3 |
1.26 |
WLOGP |
1.28 |
MLOGP |
1.25 |
ESOL Log S |
-1.34 |
ESOL Solubility (mg/ml) |
8.63 |
ESOL Solubility (mol/l) |
0.046 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.96 |
Ali Solubility (mg/ml) |
2.05 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.69 |
Silicos-IT Solubility (mg/ml) |
3.89 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.55 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.663 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.951 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |